Behçet’s disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Behçet’s disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume -, Issue -, Pages annrheumdis-2022-222277
Publisher
BMJ
Online
2022-08-04
DOI
10.1136/ard-2022-222277
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Behçet’s disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity
- (2022) Ann Cavers et al. ANNALS OF THE RHEUMATIC DISEASES
- Common allotypes of ER aminopeptidase 1 have substrate-dependent and highly variable enzymatic properties
- (2021) Jonathan P. Hutchinson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine
- (2021) Valerie Oberhardt et al. NATURE
- Identification of an Unconventional Subpeptidome Bound to the Behçet's Disease-associated HLA-B*51:01 that is Regulated by Endoplasmic Reticulum Aminopeptidase 1 (ERAP1)
- (2020) Liye Chen et al. MOLECULAR & CELLULAR PROTEOMICS
- Genome wide analysis for mouth ulcers identifies associations at immune regulatory loci
- (2019) Tom Dudding et al. Nature Communications
- Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behçet’s Disease-Associated HLA-B*51 Peptidome.
- (2019) Pablo Guasp et al. MOLECULAR & CELLULAR PROTEOMICS
- Modulation of human Th17 cell responses through complement receptor 3 (CD11 b/CD18) ligation on monocyte-derived dendritic cells
- (2018) Johannes Nowatzky et al. JOURNAL OF AUTOIMMUNITY
- Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen Loci
- (2018) Maria P. Bettinotti et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- OMIP-0XX identification, classification, and isolation of major FoxP3 expressing human CD4+ Treg subsets
- (2018) Johannes Nowatzky et al. CYTOMETRY PART A
- The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing
- (2017) Pablo Guasp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Human Leukocyte Antigen (HLA)-B27 Peptidomein Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion
- (2017) Eilon Barnea et al. MOLECULAR & CELLULAR PROTEOMICS
- A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
- (2017) Marta Łuksza et al. NATURE
- A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers
- (2016) Masaki Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- The Peptidome of Behçet's Disease-Associated HLA-B*51:01 Includes Two Subpeptidomes Differentially Shaped by Endoplasmic Reticulum Aminopeptidase 1
- (2016) Pablo Guasp et al. Arthritis & Rheumatology
- HLA-B27
- (2015) Paul Bowness Annual Review of Immunology
- Effects of polymorphic variation on the mechanism of Endoplasmic Reticulum Aminopeptidase 1
- (2015) Athanasios Stamogiannos et al. MOLECULAR IMMUNOLOGY
- 'MHC-I-opathy'—unified concept for spondyloarthritis and Behçet disease
- (2015) Dennis McGonagle et al. Nature Reviews Rheumatology
- HLA-B*51 the primary risk in Behcet disease
- (2014) G. R. Wallace PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity
- (2014) M. J. Ombrello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functionally distinctERAP1allotype combinations distinguish individuals with Ankylosing Spondylitis
- (2014) Emma Reeves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course
- (2014) Koray Tascilar et al. RHEUMATOLOGY
- Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1
- (2013) Yohei Kirino et al. NATURE GENETICS
- Immunopathogenic characterization of cutaneous inflammation in Behçet’s disease
- (2012) S. Cho et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Granulysin-producing cytotoxic T cells in the mucocutaneous lesions of Behçet disease: a distinct inflammatory response from erythema nodosum
- (2011) O. Yamasaki et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- CD8+ CD28− and CD8+ CD57+ T cells and their role in health and disease
- (2011) Marius Strioga et al. IMMUNOLOGY
- Cutting Edge: Coding Single Nucleotide Polymorphisms of Endoplasmic Reticulum Aminopeptidase 1 Can Affect Antigenic Peptide Generation In Vitro by Influencing Basic Enzymatic Properties of the Enzyme
- (2011) I. Evnouchidou et al. JOURNAL OF IMMUNOLOGY
- Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
- (2011) David M Evans et al. NATURE GENETICS
- Immunohistology of skin pathergy reaction in Behçet's disease
- (2010) A. GÜL et al. BRITISH JOURNAL OF DERMATOLOGY
- Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci
- (2010) Nobuhisa Mizuki et al. NATURE GENETICS
- Genome-wide association study identifies variants in the MHC class I, IL10 and IL23R-IL12RB2 regions associated with Behçet's disease
- (2010) Elaine F Remmers et al. NATURE GENETICS
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
- (2010) Amy Strange et al. NATURE GENETICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started